Head of complex cardiac interventions
Rabin Medical Center
Hod Hasharon, Israel
Dr. Leor Perl is the chief innovation officer and the head of the complex cardiac interventions service at the Beilinson Hospital.
Following residencies in internal medicine and general cardiology, he was the first Israeli to train at the Stanford interventional cardiology fellowship, as well as the Stanford Biodesign Fellowship.
He also holds a faculty position at the Tel-Aviv University as associate professor, and has authored more than 90 peer-reviewed articles so far.
Throughout the years, Leor took central roles in several medical device start-up companies. Subsequently, in 2018 Leor founded a new innovation center at the Beilinson Hospital, based on the biodesign method, while also adapted to the rapid implementation of needs within the hospital and the local environment. He has since led the program, charting a new model for needs-based innovation within an Israeli medical center.
Monday, February 27, 2023
5:00 PM – 6:00 PM ET
Disclosure(s): Abbott Inc: Advisor or Review Panel Member (Ongoing); Edwards Lifesciences: Advisor (Ongoing), Consultant (Ongoing); Vectorious Medical: Advisor (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Monday, February 27, 2023
5:05 PM – 5:40 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
9:00 AM – 10:00 AM ET
Disclosure(s): Abbott Inc: Advisor or Review Panel Member (Ongoing); Edwards Lifesciences: Advisor (Ongoing), Consultant (Ongoing); Vectorious Medical: Advisor (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)